Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-022111
Filing Date
2013-04-16
Accepted
2013-04-16 15:33:12
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v337472_10k.htm 10-K 1048038
2 EXHIBIT 23.1 v337472_ex23-1.htm EX-23.1 3302
3 EXHIBIT 23.2 v337472_ex23-2.htm EX-23.2 2972
4 EXHIBIT 31.1 v337472_ex31-1.htm EX-31.1 11250
5 EXHIBIT 31.2 v337472_ex31-2.htm EX-31.2 11113
6 EXHIBIT 32.1 v337472_ex32-1.htm EX-32.1 6180
  Complete submission text file 0001144204-13-022111.txt   4858206

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgrx-20121231.xml EX-101.INS 560255
8 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20121231.xsd EX-101.SCH 43928
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20121231_cal.xml EX-101.CAL 33456
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20121231_def.xml EX-101.DEF 200213
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20121231_lab.xml EX-101.LAB 344222
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20121231_pre.xml EX-101.PRE 258187
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 13763833
SIC: 2834 Pharmaceutical Preparations